Newsfile Corp
22 Sept 2026, 11:33 UTC · 2h ago
Verdict
Headline takes no side. We score RHEL +0.80 across three claims — strongly bullish.
+0.80strongly bullish
More positive than 84% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish · 2 new · 1 priced in
The Canadian Intellectual Property Office issued a new patent to Rhelion's subsidiary Filament Health regarding psychoactive alkaloid extraction and composition.
Newpress release dated September 22, 2026
So whatThis increases the total issued patent count to 78 across 13 families, strengthening the moat for PEX010's commercialization phase.
More positive than 76% of claims this week
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
Filament Health currently supplies PEX010 to more than 80 academic and philanthropic research studies worldwide.
Priced inno timing evidence provided for this specific metric
More positive than 61% of claims this week
The company plans to release a 0.5 mg dose of PEX010 to supplement the existing 1, 5, and 25 mg dosing range.
Newpress release dated September 22, 2026
More positive than 48% of claims this week
Which stocks this story touches
More positive than 84% of ticker scores this week
The company announced the issuance of a new patent by the Canadian Intellectual Property Office, strengthening its intellectual property estate.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
—
No price for RHEL right now — the quote feed didn't answer.
RHEL chart →